Sabra Q4 2022 net loss $0.37/diluted share; Normalized FFO $0.37; dividend $0.30

Sabra Health Care REIT, Inc.

2022-FY EPS reported -$0.34 revenue$624,811,000

Q4 2022 net loss per diluted share $(0.37); Normalized FFO $0.37, AFFO $0.34.
Completed transition of 24 North American facilities to Ensign/Avamere with initial annual rent $34.5M.
Acquired 85% interest in three Canadian senior housing managed JV for $52.1M at 7.6% stabilized yield.
Subsequent to Q4: $158.7M gross proceeds from dispositions; acquired managed senior housing for $40.8M at 7.3% yield.
Declared quarterly dividend $0.30/share payable Feb 28, 2023; pro forma Net Debt/EBITDA 5.38x.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sabra Health Care REIT, Inc. reported financial results for the fourth quarter of 2022.

Period: the fourth quarter of 2022
Result: reported results

Exact text from the filing

On February 21, 2023, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

Sabra Health Care REIT, Inc. filing history →

Source: SEC EDGAR

accession 0001492298-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.